21
Oct

Inovio Pharmaceuticals, AstraZeneca’s MedImmune and the University of Pennsylvania have joined forces to study influenza and antibiotic-resistant bacteria, drawing on $12.2 million in federal funds.

…read more

Source: Inovio, MedImmune and Penn unite to fight the flu on DARPA’s dime

    

0 No comments